Figure 2.
Spectral-domain OCT scans of patient 2 (left eye) demonstrate a reduction of cystoid macular edema and retinal thickness while on treatment with topical dorzolamide 2% (TID) following two and five months of treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.